ASTROTECH Corp (ASTC) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US0464843095

Price
4.20 USD
Market cap
8.94 m USD
P/E (2026)
–
P/S (2026)
9.79
Dividend yield
0.00 %
Net margin
-1,580.18 %
Return on equity (ROE)
-89.21 %
Return on assets (ROA)
-70.35 %

ASTROTECH Corp financials

Fiscal year20252026
Revenue1.00 m USD913,000.00 USD
Gross profit475,000.00 USD217,000.00 USD
Operating income-14.73 m USD-14.14 m USD
EBIT-13.85 m USD-14.89 m USD
Net income-13.85 m USD-14.43 m USD

Full history since 1994, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About ASTROTECH Corp

Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, and law enforcement centers. In addition, it develops AGLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath; and Pro-Control 1000-D2, a mass spectrometer; and EN-SCAN to detect soil, water, and air contamination source location and migration. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.